Business Context and Reporting Period
Nuveen Churchill Direct Lending Corp. filed a Form 8-K dated October 28, 2020, signed October 30, 2020. The filing reports amendments to the secured financing facility of its wholly owned subsidiary, Nuveen Churchill BDC SPV I, LLC.
Key Financial and Financing Metrics
- Maximum facility amount: Increased from $175 million to $275 million.
- Collateral: Advances are secured by a pool of eligible middle-market loans, subject to specified eligibility criteria and advance rates.
- Asset coverage requirement: The Company must maintain an asset coverage ratio of at least 1.50:1.00.
- Reinvestment period: Extended through October 28, 2023.
- Maturity date: Extended to October 28, 2025.
- Other financial metrics: The filing does not provide revenue, profit, cash flow, margin, cash balance, outstanding borrowings, or liquidity utilization figures.
Material Changes Versus the Prior Arrangement
On October 28, 2020, SPV I entered into an Omnibus Amendment to the Amended and Restated Loan and Security Agreement dated December 31, 2019. The amendment increased borrowing capacity by $100 million, extended the reinvestment and maturity dates, and made other changes to the transaction documents.
Advances may be prepaid and reborrowed during the reinvestment period. Termination or reduction of the facility before the second anniversary of the amendment date, subject to specified exceptions, may trigger a commitment reduction fee of 2% during the first year and 1% during the second year.
Outlook, Risks, Contingencies, and Unusual Items
- The expanded facility may provide additional funding capacity for eligible middle-market loan investments, although the filing does not state whether the additional capacity will be drawn.
- The asset coverage covenant and collateral eligibility requirements may limit borrowing capacity.
- Early facility reduction or termination may result in commitment reduction fees.
- The amendment constitutes a direct financial obligation of the Company for disclosure purposes under Item 2.03.
- No earnings guidance, operating outlook, defaults, contingencies, or unusual non-financing items are disclosed.
Investor Verification Checklist
- Verify the final executed amendment and the detailed eligibility criteria, advance rates, covenants, and exceptions.
- Confirm the amount drawn and available under the increased $275 million facility.
- Assess the Company’s compliance with the 1.50:1.00 asset coverage requirement.
- Review the collateral loan pool, borrowing costs, and applicable prepayment or commitment reduction fees.
- Confirm whether the extended October 28, 2025 maturity and October 28, 2023 reinvestment period remain in effect.